Skip to main content Accessibility help

Real-Time Polymerase Chain Reaction Detection of Asymptomatic Clostridium difficile Colonization and Rising C. difficile–Associated Disease Rates1

  • Hoonmo L. Koo (a1) (a2) (a3), John N. Van (a1), Meina Zhao (a1), Xunyan Ye (a1), Paula A. Revell (a4), Zhi-Dong Jiang (a2), Carolyn Z. Grimes (a2), Diana C. Koo (a2), Todd Lasco (a3), Claudia A. Kozinetz (a1), Kevin W. Garey (a2) (a3) (a5) and Herbert L. DuPont (a1) (a2) (a3) (a6)...



To evaluate the accuracy of real-time polymerase chain reaction (PCR) for Clostridium difficile–associated disease (CDAD) detection, after hospital CDAD rates significantly increased following real-time PCR initiation for CDAD diagnosis.


Hospital-wide surveillance study following examination of CDAD incidence density rates by interrupted time series design.


Large university-based hospital.


Hospitalized adult patients.


CDAD rates were compared before and after real-time PCR implementation in a university hospital and in the absence of physician and infection control practice changes. After real-time PCR introduction, all hospitalized adult patients were screened for C. difficile by testing a fecal specimen by real-time PCR, toxin enzyme-linked immunosorbent assay, and toxigenic culture.


CDAD hospital rates significantly increased after changing from cell culture cytotoxicity assay to a real-time PCR assay. One hundred ninety-nine hospitalized subjects were enrolled, and 101 fecal specimens were collected. C. difficile was detected in 18 subjects (18%), including 5 subjects (28%) with either definite or probable CDAD and 13 patients (72%) with asymptomatic C. difficile colonization.


The majority of healthcare-associated diarrhea is not attributable to CDAD, and the prevalence of asymptomatic C. difficile colonization exceeds CDAD rates in healthcare facilities. PCR detection of asymptomatic C. difficile colonization among patients with non-CDAD diarrhea may be contributing to rising CDAD rates and a significant number of CDAD false positives. PCR may be useful for CDAD screening, but further study is needed to guide interpretation of PCR detection of C. difficile and the value of confirmatory tests. A gold standard CDAD diagnostic assay is needed.

Infect Control Hosp Epidemiol 2014;35(6):667–673


Corresponding author

Address correspondence to Hoonmo L. Koo, MD, MPH, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030 (


Hide All

Presented in part: IDWeek 2013 Meeting; San Francisco, California; October 5, 2013.



Hide All
1. McDonald, LC, Owings, M, Jernigan, DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003. Emerg Infect Dis 2006;12:409415.
2. Redelings, MD, Sorvillo, F, Mascola, L. Increase in Clostridium difficile–related mortality rates, United States, 1999–2004. Emerg Infect Dis 2007;13:14171419.
3. Musher, DM, Aslam, S, Logan, N, et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 2005;40:15861590.
4. O’Horo, JC, Jones, A, Sternke, M, Harper, C, Safdar, N. Molecular techniques for diagnosis of Clostridium difficile infection: systematic review and meta-analysis. Mayo Clin Proc 2012;87:643651.
5. Schutze, GE, Willoughby, RE. Clostridium difficile infection in infants and children. Pediatrics 2013;131:196200.
6. American Society for Microbiology (ASM). A Practical Guidance Document for the Laboratory Detection of Toxigenic Clostridium difficile. Washington, DC: ASM, September 21, 2010. Accessed September 19, 2013.
7. Centers for Disease Control and Prevention. Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep 2012;61:157162.
8. Catanzaro, M, Cirone, J. Real-time polymerase chain reaction testing for Clostridium difficile reduces isolation time and improves patient management in a small community hospital. Am J Infect Control 2012;40:663666.
9. Luna, RA, Boyanton, BL Jr, Mehta, S, et al. Rapid stool-based diagnosis of Clostridium difficile infection by real-time PCR in a children’s hospital. J Clin Microbiol 2011;49:851857.
10. Fong, KS, Fatica, C, Hall, G, et al. Impact of PCR testing for Clostridium difficile on incident rates and potential on public reporting: is the playing field level? Infect Control Hosp Epidemiol 2011;32(9):932933.
11. Longtin, Y, Trottier, S, Brochu, G, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis 2013;56:6773.
12. Gould, CV, Edwards, JR, Cohen, J, et al. Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis 2013;57:13041307.
13. Kvach, EJ, Ferguson, D, Riska, PF, Landry, ML. Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection. J Clin Microbiol 2010;48:109114.
14. Borriello, SP, Honour, P. Simplified procedure for the routine isolation of Clostridium difficile from faeces. J Clin Pathol 1981;34:11241127.
15. Rosner, B. Fundamentals of Biostatistics. 5th ed. Boston: Brooks/Cole, 2000.
16. Box, GEP, Tiao, GC. Intervention analysis with applications to economic and environmental problems. J Am Stat Assoc 1975;70:7079.
17. Hall, AJ, Curns, AT, McDonald, LC, Parashar, UD, Lopman, BA. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999–2007. Clin Infect Dis 2012;55:216223.
18. Bartlett, JG. Clinical practice: antibiotic-associated diarrhea. N Engl J Med 2002;346:334339.
19. Kyne, L, Warny, M, Qamar, A, Kelly, CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000;342:390397.
20. McFarland, LV, Mulligan, ME, Kwok, RY, Stamm, WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320:204210.
21. Samore, MH, DeGirolami, PC, Tlucko, A, Lichtenberg, DA, Melvin, ZA, Karchmer, AW. Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis 1994;18:181187.
22. Riggs, MM, Sethi, AK, Zabarsky, TF, Eckstein, EC, Jump, RL, Donskey, CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 2007;45:992998.
23. Tenover, FC, Novak-Weekley, S, Woods, CW, et al. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J Clin Microbiol 2010;48:37193724.
24. Planche, TD, Davies, KA, Coen, PG, et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis 2013;13:936945.
25. Berg, AM, Kelly, CP, Farraye, FA. Clostridium difficile infection in the inflammatory bowel disease patient. Inflamm Bowel Dis 2013;19:194204.
26. Koo, HL, Ajami, NJ, Jiang, ZD, et al. A nosocomial outbreak of norovirus infection masquerading as Clostridium difficile infection. Clin Infect Dis 2009;48:e75e77.
27. Crobach, MJ, Dekkers, OM, Wilcox, MH, Kuijper, EJ. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 2009;15:10531066.
28. Deshpande, A, Pasupuleti, V, Rolston, DD, et al. Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile infection: a meta-analysis. Clin Infect Dis 2013;53:e81–e90.
29. Wilcox, MH. Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection. Clin Microbiol Infect 2012;18(suppl 6):1320.
30. Brecher, SM, Novak-Weekley, SM, Nagy, E. Laboratory diagnosis of Clostridium difficile infections: there is light at the end of the colon. Clin Infect Dis 2013;57:11751181.
31. Cohen, SH, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431455.
32. Louie, TJ, Emery, J, Krulicki, W, Byrne, B, Mah, M. OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection. Antimicrob Agents Chemother 2009;53:261263.
33. Garey, KW, Graham, G, Gerard, L, et al. Prevalence of diarrhea at a university hospital and association with modifiable risk factors. Ann Pharmacother 2006;40:10301034.

Real-Time Polymerase Chain Reaction Detection of Asymptomatic Clostridium difficile Colonization and Rising C. difficile–Associated Disease Rates1

  • Hoonmo L. Koo (a1) (a2) (a3), John N. Van (a1), Meina Zhao (a1), Xunyan Ye (a1), Paula A. Revell (a4), Zhi-Dong Jiang (a2), Carolyn Z. Grimes (a2), Diana C. Koo (a2), Todd Lasco (a3), Claudia A. Kozinetz (a1), Kevin W. Garey (a2) (a3) (a5) and Herbert L. DuPont (a1) (a2) (a3) (a6)...


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed